Carter BloodCare - Baylor

Form 483FOIA Uncovered

Dallas, Texas, United StatesFEI 1674451Issued July 25, 2019

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 1674451.

Observations1

Issue DateJuly 25, 2019

StatusNo Warning Letter

Related Inspections6

Establishment Details

Firm: Carter BloodCare - Baylor
Location: Dallas, Texas, United States
FEI Number: 1674451
Product Type: Biologics
Issue Date: July 25, 2019
Country: United States

Inspection History, 2009 to 2024

NAI5

VAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Carter BloodCare - Baylor FDA Form 483, Dallas, Texas, July 25, 2019